Group One Trading
EGRX

Group One Trading’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Group One Trading’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,000
Closed -$3.73K – 8187
2024
Q3 		$3.73K Buy
+1,000
New +$4.77K ﹤0.01% 5983
2024
Q2 		– Sell
-100
Closed -$524 – 7678
2024
Q1 		$524 Buy
+100
New +$549 ﹤0.01% 6733
2020
Q2 		– Sell
-3,000
Closed -$138K – 6292
2020
Q1 		$138K Sell
3,000
-20,000
-87% -$1M ﹤0.01% 3042
2019
Q4 		$1.38M Buy
23,000
+13,000
+130% +$775K 0.01% 1596
2019
Q3 		$566K Hold
10,000
– – ﹤0.01% 2234
2019
Q2 		$557K Buy
10,000
+9,800
+4,900% +$511K 0.01% 2041
2019
Q1 		$10K Sell
200
-19,500
-99% -$868K ﹤0.01% 4280
2018
Q4 		$794K Sell
19,700
-18,700
-49% -$964K 0.01% 1673
2018
Q3 		$2.66M Buy
38,400
+28,500
+288% +$2.16M 0.02% 951
2018
Q2 		$749K Buy
9,900
+6,600
+200% +$415K 0.01% 1973
2018
Q1 		$174K Sell
3,300
-20,600
-86% -$1.2M ﹤0.01% 2887
2017
Q4 		$1.28M Buy
23,900
+18,200
+319% +$1.01M 0.01% 1524
2017
Q3 		$340K Sell
5,700
-8,000
-58% -$484K ﹤0.01% 2369
2017
Q2 		$1.08M Buy
13,700
+12,300
+879% +$1.01M 0.01% 1399
2017
Q1 		$116K Sell
1,400
-900
-39% -$66.9K ﹤0.01% 2878
2016
Q4 		$182K Buy
2,300
+600
+35% +$43.6K ﹤0.01% 2490
2016
Q3 		$119K Sell
1,700
-16,700
-91% -$925K ﹤0.01% 2827
2016
Q2 		$714K Buy
18,400
+18,300
+18,300% +$762K 0.01% 1469
2016
Q1 		$4K Sell
100
-1,000
-91% -$63.4K ﹤0.01% 4263
2015
Q4 		$98K Buy
+1,100
New +$86.9K ﹤0.01% 2979

Other funds holding EGRX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Group One Trading's EGRX Position: Q4 2024 in Review

Group One Trading sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2024, closing a stake of 785 shares — an estimated $2.93K sold.

Group One Trading first reported a position in EGRX in Q2 2015 and held it in 9 quarters. The position peaked at $653K in Q4 2018. 9 funds tracked by Wall St. Rank hold EGRX as of Q4 2024.

  • Group One Trading reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 785 Eagle Pharmaceuticals, Inc. shares in Q4 2024, an estimated $2.93K.
  • Group One Trading first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 9 quarters.
  • Group One Trading's Eagle Pharmaceuticals, Inc. position peaked at $653K in Q4 2018.
  • 9 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.